Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: Pathophysiological implications in coronary disease

Endothelium: Journal of Endothelial Cell Research

Volumn 6, Issue 1, 1998, Pages 61-70

  Dashwood, Michael R ^a,b   Timm, Maureen ^a   Muddle, John R ^a   Ong, Albert C M ^b   Tippins, John R ^c   Parker, Robert ^d   Mcmanus, Deirdre ^d   Murday, Andrew J ^e   Madden, Brendan P ^e   Kaski, Juan Carlos ^e  

^a Department of Physiology ^*  (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Coronary vasculature; Endothelin receptors; Endothelin 1; Microvessels

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; VASOCONSTRICTOR AGENT;

ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CORONARY ARTERY; ENDOTHELIUM CELL; HEART INFARCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; TISSUE LEVEL; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

EID: 7844222810     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.3109/10623329809053405     Document Type: Article

References (36)

1. Austen, W.G., Edwards, J.E., Frye, R.L., Gensini, G., Gott, V.L., Griffith, L.S.C., McGoon, D.C., Murphy, M.L. and Roe, B.B. (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association, Circulation, 51 (suppl.), 5-40.1.
2. Barger, A.C., Beeuwkes, R., Lainey, L.L. and Silverman, K.J. (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med. 310, 175-177.
3. Cannan, C.R., Burnett Jr., J.C. and Lerman, A. (1996) Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation. 93, 646-651.
4. Carlini, R.G., Reyes, A.A. and Rothstein, M. (1995) Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 47, 740-745.
5. Chester, A.H., Dashwood, M.R., Clarke, J.G., Larkin, S.W., Davies, G.J., Tadjkarimi, S., Maseri, A. and Yacoub, M.H. (1989) Influences of endothelin on human coronary arteries and localisation of its binding sites. Am J Cardiol. 63, 1395-1398.
6. 125I]-Endothelin- 1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimai hyperplasia and atherosclerosis. JCardiovasc Pharmacol. 22(suppl 8), S343-S346.
7. 125I] endothelin binding sites in human coronary tissue. Neurochem Int. 18, 439-444.
8. B binding sites in human coronary vasculature. J Cardiovasc Pharmacol. 22(suppl 8), S351-S354.
9. A receptors. Br J Pharmacol. 111, 4-6.
10. A receptors in humans? Trends Pharmacol Sci. 15, 9-11.
11. A subtype. Br J Pharmacol. 114, 1110-1116.
12. Filep, J.G., Sirois, M.G., Rousseau, A., Fournier, A. and Sirois, P. (1991) Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet activating factor. Br J Pharmacol. 104, 797-804.
13. B receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi. Br J Pharmacol. 117, 995-999.
14. Godfraind, T. (1993) Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 110, 1201-1205.
15. Gorelova, E., Loesch, A., Bodin, P., Chadwick, L., Hamlyn, PJ. and Burnstock, G. (1996) Localisation of immunoreactive factor VIII, nitric oxide synthase, substance P, endothelin-1 and 5-hydroxytryptamine in human postmortem middle cerebral artery. J Anat. 188, 97-107.
16. Kaski, J.C., Elliott, P.M., Salomone, O., Dickinson, K., Gordon, D., Hann, C. and Holt, D.W. (1995) Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 74, 620-624.
17. A receptors are blocked. J VascRes. 33(suppl 1), 220.
18. Lerman, A., Edwards, B.S., Hallet, J.W., Heublein, D.M., Sandberg, S.M. and Burnett, J.C. Jr. (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325, 997-1001.
19. Areceptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol. 115, 191-197.
20. Marx, M., Perlmutter, R.A. and Madri, J.A. (1994) Modification of platelet-derived growth factor expression in microvascular endothelial cells during in Vitro angioneogenesis. J Clin Invest. 93, 131-137.
21. McMurdo, L., Corder, R., Thiemermann, C. and Vane, J.R. (1993) Incomplete inhibition of the pressor effects of endothelin 1 and related peptides in the anaesthatized rat with BQ123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol. 108, 557-561.
22. 1,3,11,15]ET-1 in human heart. Br J Pharmacol. 107, 637-639.
23. Moody, C.J., Dashwood, M.R., Sykes, R.M., Chester, M., Jones, S.M., Yacoub, M.H. and Harding, S.E. (1990) Functional and autoradiographic evidence for endothelin receptors on human and rat cardiac myocytes: comparison with single smooth muscle cells. Circ Res. 67, 764-769.
24. Ong, A.C.M., Jowett, T.P., Firth, J.D., Burton, S., Karet, F.E. and Fine, L.G. (1995) An endothelin-1-mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int. 48, 390-401.
25. Riggel, D.F. and Lappe, R.W. (1993) Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J Cardiovasc Pharmacol. 22(Suppl 8), S243-S247.
26. Rubanyi, G.M. and Polokoff, M.A. (1994) Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev. 46(3), 325-415.
27. Saijonmaa, O., Nyman, T. and Fyrhquist, F. (1992) Endothelin-1stimulates its own synthesis in human endothelial cells. Biochem Biophys Res Commun. 188, 286-291.
28. Sakurai, T., Yanagisawa, M. and Masaki, T. (1992) Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 13, 103-108.
29. Salomone, O., Elliott, P.M., Calvino, R., Chester, M., Holt, D. and Kaski, J.C. (1995) Endothelin-1 plasma levels are correlated with the severity of coronary atherosclerosis. Circulation. 92(8)Suppl 1, 200.
30. B receptors mediate contraction to endothelin-1in human blood vessels. Circulation. 89, 1203-1208.
31. Swerlick, R.A. and Lawley, T.J. (1993) Role of microvascular endothelial cells in inflammation. J Invest Dermatol. 100, 111S-115S.
32. Takayanagi, R., Kitazumi, K., Takasaki, C., Ohnaka, K., Aimoto, S., Tasaka, K., Ohashi, M. and Nawata, H. (1991) Presence of non selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS lett. 282, 103-106.
33. Timm, M., Kaski, J.C. and Dashwood, M.R. (1995) Endothelin-like immunoreactivity in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol. 23(Suppl 3), S442-S444.
34. Watanabe, T., Suzuki, N., Shimamoto, N., Fujino, M. and Imada, A. (1990) Endothelin in myocardial infarction. Nature. 344, 114.
35. Yanagisawa, M. and Masaki, T. (1989) Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 10, 374-379.
36. Zeiher, A.M., Ihling, C., Pistorius, K., Schachinger, V. and Schaefer, H-E. (1994) Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndrome. Lancet. 344, 1405-1406.